X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6086) 6086
Publication (667) 667
Book Review (46) 46
Book Chapter (19) 19
Conference Proceeding (5) 5
Dissertation (5) 5
Government Document (3) 3
Book / eBook (2) 2
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5207) 5207
female (3561) 3561
index medicus (3515) 3515
oncology (2859) 2859
breast cancer (2151) 2151
cancer (2147) 2147
animals (2146) 2146
receptor, erbb-2 - metabolism (1803) 1803
receptor, erbb-2 - immunology (1778) 1778
mice (1594) 1594
breast neoplasms - pathology (1355) 1355
middle aged (1343) 1343
cell line, tumor (1303) 1303
tumors (1247) 1247
receptor, erbb-2 - genetics (1190) 1190
erbb-2 protein (1131) 1131
trastuzumab (1106) 1106
expression (1090) 1090
adult (1079) 1079
breast neoplasms - metabolism (1038) 1038
aged (1032) 1032
immunohistochemistry (1008) 1008
medicine (986) 986
research article (943) 943
prognosis (939) 939
immunology (905) 905
breast neoplasms - drug therapy (837) 837
research (835) 835
gene expression (824) 824
multidisciplinary sciences (820) 820
epidermal growth factor (798) 798
chemotherapy (786) 786
proteins (784) 784
science (783) 783
breast neoplasms - genetics (774) 774
breast-cancer (749) 749
male (730) 730
metastasis (721) 721
pathology (718) 718
her2 (713) 713
analysis (712) 712
breast neoplasms - immunology (687) 687
cell biology (671) 671
kinases (653) 653
therapy (632) 632
signal transduction (630) 630
survival (607) 607
care and treatment (599) 599
health aspects (589) 589
immunotherapy (582) 582
breast (580) 580
genetic aspects (561) 561
skin and connective tissue diseases (560) 560
growth-factor receptor (549) 549
carcinoma (542) 542
biochemistry & molecular biology (528) 528
cancer therapies (527) 527
aged, 80 and over (501) 501
tumor cells, cultured (498) 498
antibodies, monoclonal - therapeutic use (494) 494
antineoplastic agents - therapeutic use (486) 486
gene expression regulation, neoplastic (485) 485
antibodies, monoclonal, humanized (481) 481
patients (479) 479
cells (470) 470
medical prognosis (460) 460
apoptosis (459) 459
medicine, research & experimental (456) 456
mice, inbred balb c (450) 450
mutation (447) 447
article (436) 436
biology (433) 433
cancer research (433) 433
monoclonal-antibody (432) 432
receptor, erbb-2 - antagonists & inhibitors (425) 425
medicine & public health (422) 422
gene amplification (417) 417
receptor (416) 416
phosphorylation (414) 414
antibodies, monoclonal - immunology (397) 397
antibodies (388) 388
receptor, erbb-2 - analysis (380) 380
cell proliferation (375) 375
medical research (374) 374
neoplasm staging (373) 373
antineoplastic agents - pharmacology (372) 372
metastases (369) 369
activation (365) 365
mice, nude (360) 360
epidermal growth factor receptors (358) 358
amplification (357) 357
receptor, erbb-2 - biosynthesis (349) 349
breast neoplasms - therapy (348) 348
treatment outcome (348) 348
biomarkers, tumor - metabolism (345) 345
receptors, estrogen - metabolism (342) 342
genes (340) 340
biomarkers (336) 336
studies (336) 336
in-vivo (330) 330
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5953) 5953
Chinese (67) 67
Japanese (36) 36
French (17) 17
German (7) 7
Spanish (5) 5
Hungarian (4) 4
Russian (4) 4
Italian (2) 2
Polish (2) 2
Finnish (1) 1
Korean (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2011, Volume 108, Issue 17, pp. 7142 - 7147
Trastuzumab, a monoclonal antibody targeting human epidermal growth factor receptor-2 (HER2/ErbB-2), has become the mainstay of treatment for HER2-positive... 
T lymphocytes | Inoculation | Medical treatment | Antibodies | Cytotoxicity | Breast cancer | Adaptive immunity | Natural killer cells | Tumors | Cancer | Natural killer cell | Innate | Adaptive | Tumor immunology | tumor immunology | TRASTUZUMAB | MECHANISM | MULTIDISCIPLINARY SCIENCES | innate | OVEREXPRESSING HER2 | COMBINATION | HER2-POSITIVE BREAST-CANCER | ADAPTIVE IMMUNITY | adaptive | IMMUNOTHERAPY | MICE | natural killer cell | PHASE-I | ESTABLISHED TUMORS | Receptor, ErbB-2 - genetics | Receptors, Interleukin-1 Type I - immunology | CD8-Positive T-Lymphocytes - transplantation | Humans | Receptors, Interleukin-17 - immunology | Receptors, Interleukin-17 - genetics | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Adoptive Transfer | Interferon Type I - immunology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Antibodies, Monoclonal, Humanized | Receptor, ErbB-2 - immunology | Interferon-gamma - genetics | Antibodies, Monoclonal - immunology | Mammary Neoplasms, Animal - genetics | Mammary Neoplasms, Animal - immunology | Antibodies, Monoclonal - pharmacology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Mice, Transgenic | Antineoplastic Combined Chemotherapy Protocols - immunology | Mice, SCID | Animals | Apoptosis Regulatory Proteins | Interferon-gamma - immunology | Receptors, Interleukin-1 Type I - genetics | Cell Line, Tumor | Interferon Type I - genetics | Programmed Cell Death 1 Receptor | Antigens, Surface | Mammary Neoplasms, Animal - drug therapy | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Trastuzumab | Biological Sciences
Journal Article
Oncogene, ISSN 0950-9232, 08/2008, Volume 27, Issue 37, pp. 5019 - 5032
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2008, Volume 358, Issue 13, pp. 1409 - 1411
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 2, pp. 134 - 141
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0131177
Antibody drug conjugates (ADCs) have recently been proven to be highly potent anti-tumor drugs, typically exceeding the efficacy of conventional monoclonal... 
RECOMBINANT IMMUNOTOXIN | IMMUNOGENICITY | MULTIDISCIPLINARY SCIENCES | PURIFICATION | SURFACE-PROTEINS | STAPHYLOCOCCUS-AUREUS | ANTITUMOR-ACTIVITY | MONOCLONAL-ANTIBODIES | FRAGMENTATION | CANCER-THERAPY | PROTEIN LIGATION | Cysteine Endopeptidases - chemistry | Staphylococcus aureus - enzymology | Aminoacyltransferases - immunology | Receptor, ErbB-2 - genetics | Humans | Bacterial Proteins - chemistry | Ovarian Neoplasms - pathology | Ki-1 Antigen - immunology | Maytansine - pharmacology | Immunoconjugates - immunology | Immunoconjugates - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Protein Engineering | Maytansine - chemistry | Female | Antineoplastic Agents - pharmacology | Bacterial Proteins - immunology | Receptor, ErbB-2 - antagonists & inhibitors | Receptor, ErbB-2 - immunology | Oligopeptides - chemistry | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Aminoacyltransferases - chemistry | Antineoplastic Agents - immunology | Maytansine - analogs & derivatives | Antibodies, Monoclonal - pharmacology | Oligopeptides - immunology | Antineoplastic Agents - chemistry | Immunoconjugates - chemistry | Staphylococcus aureus - chemistry | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Ki-1 Antigen - antagonists & inhibitors | Mice | Antibodies, Monoclonal, Humanized - immunology | Cysteine Endopeptidases - immunology | Maytansine - immunology | Trastuzumab | Antibodies, Monoclonal, Humanized - chemistry | Ki-1 Antigen - genetics | Ovarian Neoplasms - immunology | Monoclonal antibodies | Enzymes | Cysteine | Peptides | Biopharmaceutics | Drugs | Conjugates | Addition polymerization | Ovarian carcinoma | Clinical trials | Pentaglycine | Cancer therapies | Molecular weight | Ovarian cancer | Proteins | Tubulin | CD30 antigen | Xenografts | Medical research | Immunoglobulins | Polypeptides | Cloning | Polymerization | Breast cancer | ErbB-2 protein | Substrates | Chemotherapy | Lysine | Heavy chains | Toxins | Conjugation | Sortase | Tumors | Cancer
Journal Article